Javascript must be enabled to continue!
Abstract 4138686: Impact of Ejection Fraction on Incidence of Atrial Fibrillation Following Admission for Heart Failure
View through CrossRef
Introduction:
Though the prevalence of atrial fibrillation (AF) is similar amongst heart failure (HF) with reduced, mildly reduced, and preserved ejection fractions, population-level data suggests a modestly increased prevalence in patients with HFpEF compared to those HFrEF. The development of atrial fibrillation is associated with increased risk of stroke, hospitalization, and cardiovascular death in all types of heart failure, though some data suggests morbidity and mortality is worse amongst those with HFpEF. Whether ejection fraction plays a role in development of AF following a HF hospitalization is unclear.
Hypothesis:
We hypothesized incidence of AF following heart failure hospitalization is increased in patients with preserved ejection fractions.
Aim:
The goal of this study is to assess the impact of ejection fraction on development of new atrial fibrillation following heart failure exacerbation.
Methods:
Patients admitted to an academic tertiary care hospital with a primary diagnosis of HF without a previous diagnosis of AF were identified and followed for up to one year for this retrospective study. Demographic, comorbidity, medications, and echocardiography of these patients were obtained from the medical record and analyzed. Consistent with the American Heart Association heart failure guidelines, we defined HFrEF as an EF less than 40%, HFmrEF as an EF between 40-50%, and HFpEF as an EF greater than 50%. This data was analyzed on SPSS using cox-regression and Kaplan-Meier survival analysis.
Results:
Of the 3,953 patients included in our study, 22.2% had HFrEF, 13.5% had HFmrEF, and 64.3% had HFpEF. At the end of one year 23.5% of those with HFrEF, 20.1% of those with HFmrEF, and 15.9% of those with HFpEF, developed atrial fibrillation. The difference in AF incidence was noted to be statistically significantly lower in HFpEF compared to HFrEF (p<0.001) and HFmrEF (p=0.019). The difference between HFmrEF and HFrEF did not reach statistical significance (p=0.144).
Conclusion:
In patients without atrial fibrillation, a reduced ejection fraction is associated with an increased incidence of atrial fibrillation one year following a hospitalization for heart failure compared to a preserved ejection fraction.
Ovid Technologies (Wolters Kluwer Health)
Title: Abstract 4138686: Impact of Ejection Fraction on Incidence of Atrial Fibrillation Following Admission for Heart Failure
Description:
Introduction:
Though the prevalence of atrial fibrillation (AF) is similar amongst heart failure (HF) with reduced, mildly reduced, and preserved ejection fractions, population-level data suggests a modestly increased prevalence in patients with HFpEF compared to those HFrEF.
The development of atrial fibrillation is associated with increased risk of stroke, hospitalization, and cardiovascular death in all types of heart failure, though some data suggests morbidity and mortality is worse amongst those with HFpEF.
Whether ejection fraction plays a role in development of AF following a HF hospitalization is unclear.
Hypothesis:
We hypothesized incidence of AF following heart failure hospitalization is increased in patients with preserved ejection fractions.
Aim:
The goal of this study is to assess the impact of ejection fraction on development of new atrial fibrillation following heart failure exacerbation.
Methods:
Patients admitted to an academic tertiary care hospital with a primary diagnosis of HF without a previous diagnosis of AF were identified and followed for up to one year for this retrospective study.
Demographic, comorbidity, medications, and echocardiography of these patients were obtained from the medical record and analyzed.
Consistent with the American Heart Association heart failure guidelines, we defined HFrEF as an EF less than 40%, HFmrEF as an EF between 40-50%, and HFpEF as an EF greater than 50%.
This data was analyzed on SPSS using cox-regression and Kaplan-Meier survival analysis.
Results:
Of the 3,953 patients included in our study, 22.
2% had HFrEF, 13.
5% had HFmrEF, and 64.
3% had HFpEF.
At the end of one year 23.
5% of those with HFrEF, 20.
1% of those with HFmrEF, and 15.
9% of those with HFpEF, developed atrial fibrillation.
The difference in AF incidence was noted to be statistically significantly lower in HFpEF compared to HFrEF (p<0.
001) and HFmrEF (p=0.
019).
The difference between HFmrEF and HFrEF did not reach statistical significance (p=0.
144).
Conclusion:
In patients without atrial fibrillation, a reduced ejection fraction is associated with an increased incidence of atrial fibrillation one year following a hospitalization for heart failure compared to a preserved ejection fraction.
Related Results
RELATIONSHIP BETWEEN ATRIAL FIBRILLATION CARDIOVERSION AND F
RELATIONSHIP BETWEEN ATRIAL FIBRILLATION CARDIOVERSION AND F
Objectives
To investigate the relationship between atrial fibrillation cardioversion and f wave in electrocardiogram, providing an ordinary and noninvasive method...
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Inter‐Relationships Between Atrial Flutter and Atrial Fibrillation
Inter‐Relationships Between Atrial Flutter and Atrial Fibrillation
It has been appreciated for a long time that atrial flutter and atrial fibrillation have a clinical relationship. Now, with the technological advances that permit more sophisticate...
Adiponectin and Lone atrial fibrillation
Adiponectin and Lone atrial fibrillation
Objective: Lone atrial fibrillation is an idiopathic arrhythmia seen in younger individuals without any secondary disease. Adiponectin is an endogenous adipocytokine that increases...
Catheter ablation as a potential treatment alternative for atrial fibrillation among patients with heart failure with preserved ejection fraction: a retrospective cohort study
Catheter ablation as a potential treatment alternative for atrial fibrillation among patients with heart failure with preserved ejection fraction: a retrospective cohort study
Abstract
Background
In patients with heart failure with reduced ejection fraction, catheter ablation for atrial fibrillation is a useful alternative to drug-induced rhythm...
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
BackgroundA clinical dilemma exists in patients with CKD, ESKD, and after kidney transplantation, as they face concurrent risks of both thromboembolic and hemorrhagic complications...
Efficacy of SGLT2 Inhibitors in Heart Failure to Improve Ejection Fraction
Efficacy of SGLT2 Inhibitors in Heart Failure to Improve Ejection Fraction
Background: Heart failure with reduced ejection fraction is a major cause of morbidity, hospital admission, and cardiovascular mortality worldwide. Many patients end up with poor f...
Comorbidities and sex differences in chronic heart failure of ischemic etiology
Comorbidities and sex differences in chronic heart failure of ischemic etiology
Abstract
Background: Comorbidities and sex differences play a major role in chronic heart failure (CHF). However, it is unknown whether the prevalence of comorbidities diff...

